Browsing by Author Wiviott, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialKeech, Anthony (Tony); De Ferrari, Gaetano M; Deedwania, Prakash; et al, Various; Giugliano, Robert P; Gouni-Berthold, Ioanna; Kuder, J; Leiter, Lawrence A.; Murphy, Sabina A.; Sabatine, Marc S.; Wiviott, S; NH&MRC Clinical Trials CentreCardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial, The Lancet Diabetes & Endocrinology, vol.5, 12, 2017,pp 941-950
2017Evolocumab and clinical outcomes in patients with cardiovascular diseaseKeech, Anthony (Tony); et al, Various; Giugliano, Robert P; Honarpour, Narimon; Kuder, J; Liu, Thomas; Murphy, Sabina A.; Sabatine, Marc S.; Wang, Huei; Wasserman, Scott M; Wiviott, S; NH&MRC Clinical Trials CentreEvolocumab and clinical outcomes in patients with cardiovascular disease, New England Journal of Medicine, vol.376, 18, 2017,pp 1713-1722